Eligible Canadian patients with heterozygous familial hypercholesterolemia (HeFH) are one step closer to publicly funded access to cholesterol lowering treatment. MONTRÉAL, QC – Novartis Pharmaceuticals Canada Inc. is pleased to… Read More
Demonstrated significant hearing restoration in blast-induced sensorineural hearing loss models Promoted significant functional recovery and axonal regeneration in peripheral nerve injury models Reinforced NVG-291’s broad therapeutic potential with new data… Read More
LAVAL, QC – Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2%… Read More
Nimbus Synergies, one of Canada’s leading early-stage health technology investors, announced a leadership transition to support the firm’s continued growth. Co-Founder and Managing Partner Jason Robertson has been appointed Chief… Read More
With one easy blood test, Molecular You measures over 250 biomarkers, enabling more powerful and comprehensive insights for preventive and precision medicine PORTLAND, OR & VANCOUVER, BC – Molecular You,… Read More
